The Association Between Mental Health of HIV Patients and Antiretroviral Medication Adherence

authors:

avatar Mohammadreza Heydari ORCID 1 , avatar Morteza Mehraeen ORCID 1 , * , avatar Parisa Keshani ORCID 1 , avatar Marjan Faghih 2

Shiraz HIV/AIDS Research Center (SHARC), Shiraz University of Medical Sciences, Shiraz, IR Iran
Department of Biostatistics, Faculty of Medicine, Arak University of Medical Sciences, Arak, IR Iran

how to cite: Heydari M, Mehraeen M, Keshani P, Faghih M. The Association Between Mental Health of HIV Patients and Antiretroviral Medication Adherence. Int J High Risk Behav Addict. 2021;10(2):e102149. doi: 10.5812/ijhrba.102149.

Abstract

Background:

Various factors, like mental disorders, may affect the desire for medication and adherence in HIV/AIDS patients.

Objectives:

The present study aimed to determine levels of neurotic disorders and associations of disorders level and Highly Active Antiretroviral Therapy (HAART) medication adherence in HIV/AIDS patients.

Materials and Methods:

Finally, 150 patients of Behavioral Disease Counseling Center of Shiraz were selected by a convenience method and were evaluated by Symptom Checklist-25 (SCL-25) and Medication Adherence Questionnaire (MAQ). Chi-square, Kruskal-Wallis, Mann-Whitney U tests were, Spearman's correlation coefficient and logistic regression were used to analyze the data by using SPSS-20 (P < 0.05).

Results:

Seventy-eight percent of patients had normal mental health status. Also, 83% had very good medication adherence. Female gender, single or divorced, and working in temporary and low-income jobs were associated with decreased mental health status. Higher age and education were associated with increased adherence. Anxiety was the most common and effective disorder. Decreased mental health' status was shown to reduce drug adherence.

Conclusions:

Treatment of mental disorders, particularly anxiety, can be one of the most effective ways to increase drug compliance in HIV/AIDS patients.

1. Background

For those who suffer from some diseases, arbitrary discontinuation of medication may lead to the recurrence of the disease or even death; hence, medication adherence has always been an indispensable necessity, and its ensuring has been a major challenge in health policy-making (1). Medication adherence is of crucial importance for those who receive antiretroviral therapy (ART), as it has both preventive and therapeutic properties for HIV/AIDS treatment (2). Identifying factors that affect medication adherence can help physicians to address the underlying causes of low adherence, which in turn translates into an improved treatment process. Among different factors that result in low adherence, it appears that psychological factors are the most important known factor affecting medication adherence. According to studies conducted in Iran, medication adherence among Iranians is 60.4 - 69.4% (3), and some reported adherence and non-adherence of 34.4% and 64.5%, respectively (4). However, the measured adherence depends on several factors, including research setting and applied tools.

Several studies reported low levels of adherence to treatment among HIV positive patients and suggested that it can be increased by psychological consultations intended to address depression and anxiety (5, 6).

Patients' psychological motivation to continue treatment is a crucial factor. Patients may lose their interest in completing treatment for reasons such as mental disorders, desire for suicide, depression, and fear of treatment stages (7). On the other hand, numerous scientific reports confirmed that mental disorders like borderline personality disorder, mood disorders, and anxiety disorder are common among this group (8). Psychiatric patients have low levels of medication adherence, and their possibility of medication withdrawal is very high (9).

The extent to which this adherence is based on the current mental state of patients can be evaluated from two perspectives. First, the mental state of these individuals depends on the experienced conditions, which may lead to medication adherence or withdrawal. Second, the incidence or improvement of psychological diseases during the HIV patient treatment can increase or decrease the tendency to the highly active ART (HAART) medication adherence.

2. Objectives

The present study intended to: (1) determine the mental state of HIV+ patients, (2) determine the rate of medication adherence in HIV+ patients, and (3) determine the association between types and level of mental disorder and rate of antiretroviral medication adherence in patients.

3. Materials and Methods

Following a cross-sectional design, the current study was conducted at the Behavioral Disease Counseling Center of Shiraz. The final sample size was calculated as 150 subjects following similar studies with a confidence interval of 95% (4), with special emphasis on medication adherence. Informed written consent was obtained from all participants, which was tuned by the Vice-Chancellor for Research of the Shiraz University of Medical Sciences. All patients were included in the study, except for the people who had completed the questionnaire.

3.1. Ethics

Before asking participants to fill the data collection tools, all participants were asked to fill the written informed consent. In addition, all principles of the Helsinki declaration and its further amendment were followed. The study was approved by the Medical Ethics Committee on Human Research of Shiraz University of Medical Sciences (code: IR.SUMS.REC.1398.550), without the need to record IRCT.

According to one study, very good medication adherence was defined as the use of over 97% of medications prescribed by a physician for HIV/AIDS treatment (10); and mental disorder was determined based on the participants' score in the Symptom Checklist-25 (SCL-25).

3.2. Research Tools

3.2.1. Symptom Checklist-25 (SCL-25)

It is a 25-item checklist intended to assess mental disorders in both healthy and HIV/AIDS cases. This checklist is scored on a five-point Likert scale, ranging from "Never" to "strongly". It has 8 subscales, namely somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobia, paranoia, and Psychoticism. A Cronbach's alpha of 0.97 is reported for this checklist (11).

3.2.2. Adherence Questionnaire in Patients with Chronic Diseases

This 40-item questionnaire has been designed and standardized by Seyed Fatemi et al. (2018) at Gorgan University to measure seven factors in medication adherence: intention to treat; the desire to participate in therapy; ability to adapt; the combination of treatment with life; medication adherence; commitment to medication; and uncertainty about treatment. The medication adherence determines based on the total score, as follows: a score of 0 - 25 is defined as weak, 26-50 as medium, 51 - 74 as good, and 75 - 100 as very good. Its reliability is evaluated by the test-retest technique. Also, its internal consistency is confirmed with a Cronbach's alpha of 0.92 (10).

Statistical analysis was administered using SPSS version 20. Statistical significance was considered when P-value < 0.05. All study variables were evaluated in terms of normal distribution, and the distribution of all quantitative variables was abnormal. Chi-square, Kruskal-Wallis, and Mann-Whitney U tests were used to test the qualitative variables. The correlation of the quantitative variables was investigated using Spearman's correlation coefficient. The association between main quantitative variables, including medication adherence and mental state, was evaluated using the logistic regression, with s cut-off value of 75% for medication adherence using the logistic regression test.

Logistic regression analysis was performed to investigate the association between the medication adherence and mental state in patients with HIV/ AIDS by considering a cut-off rate of 5% for medication adherence and considering variables of age, marital status, employment status, and the transmission way of HIV/AIDS in the univariate analysis. Statistical significance was considered when P-value < 0.2.

4. Results

4.1. Demographic Data

In the present study, 58 (38.7%) participants were male, with a mean age of 43.5 ± 9.6 years; and 91 (60.7%) were female, with a mean age of 40.6 ± 7.05 years. Six (2%) participants were under 20 years and over 60 years. The minimum and maximum age of HIV diagnosis were 4 and 67 years, respectively.

Also, the mother language of 118 (78.6%) participants was Farsi. All of the participants were Muslim. Only 6 (4%) participants had a college education. Except for 15 (10%) patients, all of them were educated in Shiraz or its suburbs. Seventy-seven (31%) were single or divorced, and 86 (58%) were unemployed. Sixty-eight (98%) of female participants and 3 (1.5%) of male participants were infected through sexual intercourse. Furthermore, 48 (95.5%) males and 2 (4.5%) females were infected through intravenous injection.

4.2. Findings

4.2.1. Determinants of Mental State

As shown in Table 1, only somatization and interpersonal sensitivity (*) were significantly different between males and females.

Table 1. Mental Health of HIV Patients by Gender
ScaleFrequency (%)Frequency (%) in Sex
MaleFemale
Somatization
Normal98 (65.3)46 (79.31) *52 (57.77) *
Pathologic49 (32.70)10 (17.24)38 (42.22)
Psychotic2 (1.3)2 (3.44)0
Obsessive-compulsive
Normal99 (65.3)43 (76.78)56 (62.22)
Pathologic98 (66)12 (21.42)26 (28.88)
Psychotic4 (2.7)1 (1.78)3 (3.3)
Interpersonal sensitivity
Normal43 (28.7)25 (43.1) *18 (20) *
Pathologic90 (60)29 (50)60 (66.66)
Psychotic16 (10.7)4 (6.89)12 (13.33)
Depression
Normal79 (52.7)36 (62.06)43 (47.77)
Pathologic57 (38)15 (25.86)41 (45.05)
Psychotic13 (8.5)7 (12.6)6 (6.59)
Anxiety
Normal110 (73.3)43 (74.13)67 (74.44)
Pathologic33 (22)13 (22.41)20 (21.97)
Psychotic6 (4)2 (3.44)3 (33.3)
Phobia
Normal133 (88.7)53 (91.37)80 (87.91)
Pathologic15 (10)4 (6.98)10 (10.98)
Psychotic2 (1.3)1 (1.72)1 (1.09)
Paranoia
Normal90 (60)38 (65.51)52 (57.77)
Pathologic30 (20)16 (27.58)31 (34.06)
Psychotic25 (16.7)4 (6.89)7 (7.69)
Psychoticism
Normal122 (81.3)46 (80.70)76 (84.44)
Pathologic24 (16)9 (15.78)14 (15.55)
Psychotic2 (1.3)2 (3.5)0

According to the results of the SCL25, 78% of patients had normal mental health status, 21% had morbidity, and 1% had psychosis. Moreover, their difference was significant (P-value = 0.002), and the prevalence of the disorder was slightly higher in females than males (mean rank of 56.81 for males and 77.91 for females), which can be attributed to the difference between items of "somatization" and "interpersonal sensitivity" (P ≤ 0.05).

The general mental state of patients showed a significant difference in marital status (P-value= 0.012) and employ status (P-value = 0.008). Married and employed participants had better status than other groups. In all items, the somatization (P-value = 0.023) disorder was significantly higher in married participants. Obsessive-compulsive disorder (OCD) (P-value = 0.016) and anxiety (P-value = 0.026) were significantly depended to job. For other items, there was no significant difference concerning overall mental state.

4.2.2. Medication Adherence

In the present study, 82.7% of respondents had very good medication adherence, 12.7% good, and 0.7 moderate, and none of them had low adherence. The difference between males and females was not statistically significant (P-value = 0.613).

The percentage of medication adherence was significantly different between various age groups (P-value = 0.024) and different levels of education (P-value = 0.024), so that the higher the age or education, the higher was the adherence. For other items, there was no significant difference concerning the medication adherence.

4.2.3. The Association Between Mental State and Medication Adherence

According to the findings, there was an inverse correlation between medication adherence and the overall mental state (r = -0.269, P-value = 0.002).

Some psychological items such as OCD (r = -0.291), depression (r = -0.175), anxiety (r = -0.227), phobia (r = -0.335), paranoia (r = -0.232), and Psychoticism (r = 0.251) were significantly correlated with medication adherence. Furthermore, there was a significant negative association between three levels of adherence and total psychological score (P < 0.05). As the association was inverse, it can be argued that the higher the total score of mental state, the lower will be the score of all scales (at a normal level), which causes increase adherence (Table 2).

Table 2. Adherence Rates Base on Mental Status of Patients
Psychological ScalesLevel of Adherence
Somatization
Normal83111
Pathologic4140
Psychotic020
Obsessive-compulsive
Normal7881
Pathologic3070
Psychotic220
Interpersonal sensitivity
Normal3850
Pathologic7391
Psychotic1230
Depression
Normal6861
Pathologic4780
Psychotic830
Anxiety
Normal9881
Pathologic1990
Psychotic600
Phobia
Normal113131
Pathologic1030
Psychotic110
Paranoia
Normal8050
Pathologic3881
Psychotic640
Psychoticism
Normal105101
Pathologic1760
Psychotic110

Logistic regression analysis was used to analyze the association between compliance with drug adherence and mental status in patients with HIV/ AIDS. A cut-off value of 75% was considered for the adherence. Confounders such as age, marital status, employment status, and the roots of transmission were also considered, which had a P–value < 0.2 in the univariable analysis. A significant association was found between compliance and mental status, which means a positive association between mental state the chance of adherence (more than 69%) (OR = 0.31; CI 95%, 0.10-0.94; P-value = 0.040) (Table 3).

Table 3. Association Between Mental Health and Adherence Using Logistic Regression
ORCI 95%P Value
LowerUpper
Mental health status0.3160.1050.9470.04*
Age
10 - 3010.602
31 - 400.3790.013110.1970.574
41 - 5010.3050.046360.8400.876
51 - 6020.5120.0010.0010.998
61 - 9010.8130.0010.0010.999
Marital status
Single10.285
Married40.9960.629390.6770.128
Divorced/ widowed20.2470.258190.5450.463
Job status10.098
Self-employed10.12610.150100.7620.037*
Employed30.9150.0010.0010.999
Unemployed60.79710.27730.6180.025*
Roots of transmission
Sex10.834
Drug injection0.8590.14750.0210.866
Medical transmission and tattoo0.0010.00100.0011.000
Unknown30.7450.34540.6540.278
Mother70.4200.00100.0011.000

5. Discussion

Medication adherence is an important issue that is under the influence of several individual or social factors such as psychological structure and type of psychological status. The present study aimed to determine the mental state of HIV/AIDS patients. According to the findings, 21% of patients had morbidity, and 1% had a psychotic disorder. A study reported that about 30% of patients received psychiatric treatment, which corresponded to 78% of patients' mental health (4). The results also indicated no significant difference between medication adherence in those with and without psychiatric treatment (P-value = 0.27). Some field studies indicated that those who received ongoing training in resilience, dealing with problems, social communications, how to cope with illness as well as medication consultation, medication adherence, and so on had better mental health. The above findings are consistent with those reported by Fawzi (2016), Johnsson et al. (2013), and Olley et al. (2004) (12-14).

Also, female's mental state was slightly more unstable than males, which can be attributed to the focus of SCL25 on neurotic axes and the higher prevalence of disorders among females (15). The difference was due to a significant difference in interpersonal sensitivity and somatization in both genders. As HIV diagnosis is associated with increased psychosomatic state and even may cause hypochondria, and since females are at enhanced risk of such states, the Somatization was higher in women. Furthermore, because of social problems such as stigma and discrimination in HIV cases, the interpersonal sensitivity scale was more appropriated for data collection (16). Concerning the HIV transmission method and patients' mental state, there was no significant difference in the total scores of individuals; however, there was a significant difference between somatization and interpersonal sensitivity scales.

Based on the findings, widows/widowers, those who were divorced, and those with temporal marriage, and unemployed people had worsened mental state; Nevertheless, those working in the public sector had better mental health state, which is consistent with studies by Horowitz (2004) and Paul & Moser (2009) and DSM5 report (2013) (17-19).

As mentioned before, our study also intended to determine the rate of medication adherence, and it was found that a majority of patients had a very good (a level of 75 - 100%) medication adherence (9). Some studies with a similar research design reported that those with less than 90% or 95% of adherence had continuous drug use (4, 20). The current study was based on a questionnaire that contained four levels of adherence (i.e., very good, good, moderate, and weak). Using a cut-off value of > 90% for adherence level, none of the participants had very good adherence, as the highest adherence score was 89. Also, 82% of participants had good medication adherence. A number of researchers believed using a categorization of adhered and non-adhered decreases the success rate (i.e., < 5%), due to various reasons, which results in social stigma.

The study showed that age is a cornerstone of medication adherence. That is, the higher the age, the more the medication adherence. Therefore, medication non-adherence or poor adherence, which occurs at very young ages, is risky behavior, which is consistent with the study by Barclay et al. (2007) (21). Some studies reported poor adherence at older ages (22) among those who suffered from neuropsychiatric disorders. As it is not in line with the findings of the present study, mainly because our center did not admit any case with neurological disorders during the study period. A similar association was found concerning the variable of education. So that, the higher the education, the higher the medication adherence, which is consistent with studies by Reisner (2009) and Murphy (2010) (23, 24).

The third aim of the current study was to investigate the association between mental state and medication adherence. According to the association between total score and mental state and each mental scale with medication adherence, a significant association was found between total score and eight items of psychological scales (i.e., obsessive-compulsive, anxiety, depression, phobia, and Psychoticism) and medication adherence. In other words, the higher the total score of mental state, the lower will be the score of the abovementioned scales, and the more the medication adherence, the higher the adherence level. In other words, those with a better mental state have higher medication adherence. Furthermore, the multivariate analysis of variance indicated that anxiety was the most important factor among 8 items of mental disorders. In the existence of anxiety, other psychological factors had lower effects on medication adherence. The findings of the present study are consistent with those reported by DiMatteo, Lepper, and Croghan (2000), Valente (2003), Safren et al. (2004), and Ingersoll (2004) (25-28).

5.1. Conclusion

The findings of the present study are not consistent with those reported by several previous studies that investigated the effectiveness of psychological factors that affect medication adherence in those who suffer from HIV/AIDS. The current study also investigated the impact of neurotic factors in medication adherence in HIV patients, using a pathological questionnaire. In general, gender, marital status, and employment could affect mental health in a way that female gender, being single or divorced, and having temporary and low-income jobs were associated with lower levels of mental health.

On the other hand, age and education had an impact on medication adherence. So that the higher the age and education, the higher the medication adherence. Hence, it can be argued that almost all psychological items could affect medication adherence. Therefore, psychological treatment should be a top priority in HIV/AIDS infected cases that suffer from mental disorders. Among the treatment of neurotic disorders, the treatment of anxiety disorders is at the forefront of treatment.

5.2. Limitations

The limitations of the present study are as follows: (1) Sometimes, people's desire decreased for cooperation because of the problems of HIV. (2) Patients were usually in a hurry and there was not enough time for questioning. (3) Access to both sexes and in the same demographic situations was not possible.

Acknowledgements

References

  • 1.

    Munro S, Lewin S, Swart T, Volmink J. A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health. 2007;7:104. doi: 10.1186/1471-2458-7-104. [PubMed: 17561997]. [PubMed Central: PMC1925084].

  • 2.

    Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns. 2002;46(2):93-108. doi: 10.1016/s0738-3991(01)00219-1. [PubMed: 11867239].

  • 3.

    Khalili H, Rohani R, Seyedalinaghi S, Hajiabdolbaghi M, Dashti-Khavidaki S, Talasaz AH. Adherence to antiretroviral therapy among Iranian HIV/AIDS patients. Curr Clin Pharmacol. 2012;7(2):111-5. doi: 10.2174/157488412800228910. [PubMed: 22432842].

  • 4.

    Ebrahimzadeh Z, Goodarzi MA, Joulaei H. The clarification of depression and social support's contribution to the prediction of antiretroviral medication adherence and the rate of CD4 in people with HIV. Glob J Health Sci. 2016;8(9):54842. doi: 10.5539/gjhs.v8n9p165. [PubMed: 27157183]. [PubMed Central: PMC5064086].

  • 5.

    Nakimuli-Mpungu E, Bass JK, Alexandre P, Mills EJ, Musisi S, Ram M, et al. Depression, alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: a systematic review. AIDS Behav. 2012;16(8):2101-18. doi: 10.1007/s10461-011-0087-8. [PubMed: 22116638].

  • 6.

    Farhoudi B, Alipour A, Ghodrati S, Seyedalinaghi S, Zanganeh M, Mohraz M. Barriers to adherence to antiretroviral treatment among inmates of a Prison in Tehran, Iran: A qualitative study. Archives of Clinical Infectious Diseases. 2018;13(2). doi: 10.5812/archcid.57911.

  • 7.

    Springer SA, Dushaj A, Azar MM. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review. AIDS Behav. 2012;16(8):2119-43. doi: 10.1007/s10461-012-0212-3. [PubMed: 22644066]. [PubMed Central: PMC3481055].

  • 8.

    Agarwal P, Aswal S, Gupta L, Verma K, Singhal A, Gupta P. Personality psychopathology in HIV infected patients. Delhi Psychiatry J. 2012;15(1):183-7.

  • 9.

    Adams J, Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand. 2000;101(2):119-24. doi: 10.1034/j.1600-0447.2000.90061.x. [PubMed: 10706011].

  • 10.

    Seyed Fatemi N, Rafii F, Hajizadeh E, Modanloo M. Psychometric properties of the adherence questionnaire in patients with chronic disease: A mix method study. Koomesh. 2018;20(2):179-91.

  • 11.

    Najarian B, Davoodi I. Manufacture and Validation of SCL-25 (Short Form SCL-90-R). J Spychol. 2001;5(2):136-49.

  • 12.

    Smith Fawzi MC, Ng L, Kanyanganzi F, Kirk C, Bizimana J, Cyamatare F, et al. Mental health and antiretroviral adherence among youth living with HIV in Rwanda. Pediatrics. 2016;138(4). doi: 10.1542/peds.2015-3235. [PubMed: 27677570]. [PubMed Central: PMC5051202].

  • 13.

    HIV Clinicians Society Southern African. Management of mental health disorders in HIV-positive patients: : by the Southern African HIV clinicians Society. 2013. 2013;14(4):11. doi: 10.4102/sajhivmed.v14i4.50.

  • 14.

    Olley BO, Gxamza F, Seedat S, Theron H, Taljaard J, Reid E, et al. Psychopathology and coping in recently diagnosed HIV/AIDS patients--the role of gender. S Afr Med J. 2004;10(1):21-4.

  • 15.

    American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub; 2013.

  • 16.

    Olley BO, Gxamza F, Seedat S, Theron H, Stein DJ, Taljaard J, et al. Psychopathology and coping in recently diagnosed HIV/AIDS patients—the role of gender. S Afr Med J. 2003;93(12):928-31. [PubMed: 14750493].

  • 17.

    American Psychiatrie Association. Diagnostic and statistical manua/of mental disorders. 17. BMC Med; 2013. p. 133-7.

  • 18.

    Horowitz LM. Interpersonal foundations of psychopathology. Washington DC: American Psychological Association; 2004. doi: 10.1037/10727-000.

  • 19.

    Paul KI, Moser K. Unemployment impairs mental health: Meta-analyses. Journal of Vocational Behavior. 2009;74(3):264-82. doi: 10.1016/j.jvb.2009.01.001.

  • 20.

    Ebrahimzadeh Z, Goodarzi MA, Joulaei H. Predicting the Antiretroviral Medication Adherence and CD4 Measure in Patients with HIV/AIDS Based on the Post Traumatic Stress Disorder and Depression. Iran J Public Health. 2019;48(1):139-46. [PubMed: 30847322]. [PubMed Central: PMC6401591].

  • 21.

    Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26(1):40-9. doi: 10.1037/0278-6133.26.1.40. [PubMed: 17209696]. [PubMed Central: PMC2863998].

  • 22.

    Ettenhofer ML, Hinkin CH, Castellon SA, Durvasula R, Ullman J, Lam M, et al. Aging, neurocognition, and medication adherence in HIV infection. Am J Geriatr Psychiatry. 2009;17(4):281-90. doi: 10.1097/JGP.0b013e31819431bd. [PubMed: 19307857]. [PubMed Central: PMC2679810].

  • 23.

    Murphy DA, Lam P, Naar-King S, Harris DR, Parsons JT, Muenz LR, et al. Health literacy and antiretroviral adherence among HIV-infected adolescents. Patient education and counseling. JMIR Res Protoc. 2010;79(1):25-9. doi: 10.1016/j.pec.2009.07.014.

  • 24.

    Reisner SL, Mimiaga MJ, Skeer M, Perkovich B, Johnson CV, Safren SA. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med. 2009;17(1):14-25. [PubMed: 19270345]. [PubMed Central: PMC3752381].

  • 25.

    DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-7. doi: 10.1001/archinte.160.14.2101. [PubMed: 10904452].

  • 26.

    Valente SM. Depression and HIV disease. J Assoc Nurses AIDS Care. 2003;14(2):41-51. doi: 10.1177/1055329002250993. [PubMed: 12698765].

  • 27.

    Safren SA, O'Cleirigh C, Tan JY, Raminani SR, Reilly LC, Otto MW, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28(1):1-10. doi: 10.1037/a0012715. [PubMed: 19210012]. [PubMed Central: PMC2643364].

  • 28.

    Ingersoll K. The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care. 2004;16(2):199-211. doi: 10.1080/09540120410001641048. [PubMed: 14676026].

Copyright © 2021, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.